Last 48 quarters of trend data · Healthcare · Medical - Care Facilities
Quarterly valuation ratios — annualised for comparability. YoY Δ shows same-quarter-prior-year change.
| Metric | TTM | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 | Q3 '23 | Q2 '23 | Q1 '23 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| P/E Ratio → | -1.93 | — | 15.47 | 17.19 | 84.22 | 28.32 | 21.42 | 19.86 | 23.86 | 30.86 | — | 25.20 | 25.09 |
| — | — | -27.8% | -13.5% | +253.0% | -8.2% | — | -21.2% | -4.9% | +0.5% | — | +31.2% | +2.6% | |
| P/S Ratio | 0.64 | 0.39 | 0.66 | 0.59 | 0.91 | 1.18 | 1.79 | 1.95 | 2.37 | 2.40 | 2.14 | 2.49 | 2.34 |
| — | -66.8% | -63.3% | -69.8% | -61.8% | -51.0% | -16.1% | -21.7% | +1.2% | -14.1% | -20.6% | +5.0% | -3.1% | |
| P/B Ratio | 0.99 | 0.60 | 0.68 | 0.64 | 0.88 | 1.14 | 1.86 | 2.03 | 2.45 | 2.47 | 2.28 | 2.42 | 2.25 |
| — | -47.5% | -63.3% | -68.6% | -64.1% | -53.8% | -18.5% | -16.2% | +8.7% | -5.1% | -9.9% | +7.2% | -0.1% | |
| P/FCF | — | — | — | — | — | — | — | 91.93 | — | — | 163.40 | 24.99 | — |
| — | — | — | — | — | — | — | +267.9% | — | — | — | +8.7% | — | |
| EV / EBITDA | 8.02 | 10.15 | 6.81 | 5.63 | 20.42 | 9.89 | 10.51 | 11.35 | 13.92 | 13.33 | — | 7.38 | 7.61 |
| — | +2.7% | -35.2% | -50.4% | +46.7% | -25.8% | — | +53.7% | +82.8% | +55.2% | — | +2.8% | -2.8% | |
| EV / EBIT | 11.93 | 19.90 | 14.85 | 12.64 | 29.47 | 20.77 | 15.13 | 14.96 | 17.84 | 17.10 | — | 16.12 | 18.07 |
| — | -4.2% | -1.8% | -15.5% | +65.2% | +21.4% | — | -7.2% | -1.3% | -18.1% | — | +3.1% | -4.3% |
Quarterly margins and returns. Watch for margin compression across consecutive quarters.
Acadia Healthcare Company, Inc.'s operating margin was 5.8% in Q4 2025, down 8.2 pp QoQ and down 7.6 pp YoY. This marks the 3rd consecutive quarter of margin compression, signaling a persistent pressure on profitability that investors should monitor. The trailing four-quarter average of 9.5% exceeds the current quarter, suggesting the latest result may reflect seasonal weakness or a one-off headwind. Gross margin contracted 87.9% YoY, suggesting cost inflation or competitive pricing pressure.
| Metric | TTM | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 | Q3 '23 | Q2 '23 | Q1 '23 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | 17.6% | 11.7% | 96.4% | 96.7% | 32.6% | 96.3% | 96.4% | 24.0% | 22.7% | 23.0% | 96.4% | 43.6% | 40.8% |
| — | -87.9% | +0.1% | +303.6% | +43.4% | +319.4% | -0.0% | -45.0% | -44.2% | -45.3% | +122.7% | -1.2% | -2.3% | |
| Operating Margin | 11.7% | 5.8% | 14.0% | 16.4% | 1.7% | 13.4% | 18.0% | 17.9% | 16.8% | 16.8% | — | 36.0% | 33.3% |
| — | -56.6% | -22.2% | -8.7% | -89.6% | -20.6% | — | -50.2% | -49.6% | -50.9% | — | -0.5% | -1.8% | |
| Net Margin | -33.3% | -143.3% | 4.3% | 3.5% | 1.1% | 4.2% | 8.4% | 9.9% | 9.9% | 7.8% | -29.0% | 9.9% | 9.4% |
| — | -3502.8% | -49.0% | -64.8% | -89.1% | -45.8% | +128.8% | -0.3% | +6.1% | -14.1% | -372.1% | -19.5% | -5.0% |
| Metric | TTM | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 | Q3 '23 | Q2 '23 | Q1 '23 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ROE | -41.4% | -43.4% | 1.1% | 0.9% | 0.3% | 1.0% | 2.2% | 2.6% | 2.6% | 2.0% | -7.5% | 2.4% | 2.3% |
| — | -4312.8% | -49.3% | -63.8% | -89.9% | -49.2% | +129.3% | +6.8% | +15.1% | -5.0% | -393.0% | -18.2% | -2.7% | |
| ROA | -19.2% | -19.7% | 0.6% | 0.5% | 0.1% | 0.6% | 1.2% | 1.4% | 1.4% | 1.1% | -4.1% | 1.4% | 1.3% |
| — | -3676.4% | -51.7% | -65.5% | -90.1% | -48.9% | +128.4% | -1.1% | +6.7% | -12.4% | -386.6% | -13.9% | +3.9% | |
| ROIC | 5.9% | 0.7% | 1.6% | 2.0% | 0.2% | 1.5% | 2.2% | 2.2% | 2.1% | 2.2% | — | 4.5% | 4.0% |
| — | -53.8% | -26.4% | -9.8% | -91.0% | -31.4% | — | -51.2% | -47.6% | -45.4% | — | +4.5% | +5.3% |
Quarterly solvency trend — watch for debt spikes or covenant pressure.
Acadia Healthcare Company, Inc.'s Debt/EBITDA ratio is 28.3x, up from 14.5x last quarter — elevated, raising questions about debt serviceability. The current ratio has improved 55.1% YoY to 1.55x, strengthening the short-term liquidity position.
| Metric | TTM | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 | Q3 '23 | Q2 '23 | Q1 '23 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debt / Equity | 1.23 | 1.23 | 0.74 | 0.74 | 0.73 | 0.65 | 0.64 | 0.64 | 0.67 | 0.52 | 0.54 | 0.51 | 0.53 |
| — | +88.9% | +15.5% | +14.9% | +9.8% | +24.9% | +19.0% | +26.4% | +25.2% | -0.8% | -1.6% | -10.0% | -13.5% | |
| Debt / EBITDA | 4.58 | 28.30 | 14.53 | 12.47 | 37.82 | 14.58 | 10.88 | 11.04 | 12.02 | 9.42 | — | 5.20 | 5.87 |
| — | +94.1% | +33.6% | +13.0% | +214.5% | +54.8% | — | +112.3% | +104.7% | +61.2% | — | -11.2% | -14.3% | |
| Current Ratio | 1.55 | 1.55 | 1.44 | 1.32 | 1.35 | 1.00 | 1.07 | 1.18 | 1.27 | 0.67 | 0.81 | 1.34 | 1.42 |
| — | +55.1% | +35.0% | +11.9% | +6.6% | +48.5% | +31.5% | -11.8% | -11.0% | -48.4% | -37.5% | +14.1% | +10.2% | |
| Quick Ratio | 1.55 | 1.55 | 1.43 | 1.31 | 1.34 | 0.99 | 1.06 | 1.17 | 1.25 | 0.67 | 0.81 | 1.33 | 1.41 |
| — | +56.7% | +35.0% | +11.9% | +6.6% | +48.4% | +31.4% | -11.8% | -10.9% | -48.3% | -37.4% | +14.1% | +10.1% | |
| Interest Coverage | 2.79 | 1.26 | 3.26 | 4.05 | 0.46 | 3.44 | 4.92 | 4.89 | 4.74 | 6.11 | — | 12.58 | 11.73 |
| — | — | — | — | — | — | — | — | — | — | — | — | — |
Includes 30+ ratios · 48 years · Updated daily
Price is only half the story. See total return with reinvested dividends.
Launch CalculatorSee our Bear / Base / Bull DCF models and intrinsic value estimates.
View ValuationCompare performance and metrics against top competitors.
Start ComparisonAcadia Healthcare Company, Inc.'s current P/E is -1.9x. The average P/E over the last 3 quarters is 39.0x. Quarterly P/E ratios can vary due to seasonal revenue patterns and one-time charges.
Acadia Healthcare Company, Inc.'s current operating margin is 11.7%. Margins have been expanding over recent quarters. Quarterly margins are particularly useful for identifying trend inflections that annual data smooths over.
Quarterly financial ratios reveal short-term trend shifts — margin compression, debt spikes, or valuation re-ratings — that annual figures smooth over. They're essential for active investors tracking Acadia Healthcare Company, Inc.'s business trajectory between earnings reports.